Lawson-Michod, Katherine A.
Watt, Melissa H.
Grieshober, Laurie
Green, Sarah E.
Karabegovic, Lea
Derzon, Samantha
Owens, Makelle
McCarty, Rachel D.
Doherty, Jennifer A.
Barnard, Mollie E.
Article History
Received: 29 August 2022
Accepted: 14 October 2022
First Online: 4 November 2022
Declarations
:
: The study was reviewed by the University of Utah’s Institutional Review Board and was determined to be exempt on 8/30/2019. Per the approved protocol, all patient participants had previously provided written informed consent agreeing to participate in Huntsman Cancer Institute Total Cancer Care Study. All participants also received a consent cover letter describing the study by email, and verbal consent was obtained from patient and provider participants prior to interview. Prior written consent for the Huntsman Cancer Institute Total Cancer Care Study and subsequent verbal consent prior to patient and provider interviews was approved by University of Utah’s Institutional Review Board on 8/30/2019. All research was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: Mollie E. Barnard reports personal fees from Epi Excellence LLC outside of the submitted work. Katherine A. Lawson-Michod reports compensation from Foundation Medicine for work outside of the submitted work. All other co-authors declare no potential competing interests.